Combination of haptoglobin and osteopontin could predict colorectal cancer hepatic metastasis

Annals of Surgical Oncology

Volumn 19, Issue 7, 2012, Pages 2411-2419

  Sun, Lichao ^a   Pan, Jian ^b   Peng, Liang ^c   Fang, Lv ^a   Zhao, Xuan ^a   Sun, Lixin ^a   Yang, Zhihua ^a   Ran, Yuliang ^a  

^a CANCER HOSPITAL   (China)

^b CHILDREN S HOSPITAL OF SOOCHOW UNIVERSITY   (China)

^c CHINA JAPAN FRIENDSHIP HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CARCINOEMBRYONIC ANTIGEN; HAPTOGLOBIN; MOLECULAR MARKER; OSTEOPONTIN;

ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; CANCER STAGING; CLINICAL FEATURE; COLORECTAL CANCER; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; FEMALE; GENE EXPRESSION PROFILING; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LIVER METASTASIS; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; PREDICTIVE VALUE; PRIMARY TUMOR; PROTEIN EXPRESSION; SENSITIVITY AND SPECIFICITY;

ADULT; AGED; AGED, 80 AND OVER; COLORECTAL NEOPLASMS; CYTOCHROME P-450 ENZYME SYSTEM; FEMALE; HAPTOGLOBINS; HUMANS; IMMUNOENZYME TECHNIQUES; LIVER NEOPLASMS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM STAGING; OSTEOPONTIN; PROGNOSIS; SURVIVAL RATE; TISSUE ARRAY ANALYSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 84865137067     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/s10434-011-2177-2     Document Type: Article

References (34)

1. Parkin DM, Bray F, Ferlay F, Pisani P. Global cancer statistics, 2002. CA Cancer J Clin. 2005;55:74-108. (Pubitemid 40372904)
2. Manfredi S, Lepage C, Hatem C, Coatmeur O, Faivre J, Bouvier AM. Epidemiology and management of liver metastases from colorectal cancer. Ann Surg. 2006;244:254-9. (Pubitemid 44305540)
3. McMillan DC, McArdle CS. Epidemiology of colorectal liver metastases. Surg Oncol. 2007;16:3-5. (Pubitemid 46887664)
4. Angelopoulos S, Kanellos I, Christophoridis E, Tsachalis T, Kanellou A, Betsis D. Five-year survival after curative resection for adenocarcinoma of the colon. Tech Coloproctol. 2004; 8(Suppl. 1):S152-4.
5. Bakalakos EA, Kim JA, Young DC, Martin EW Jr. Determinants of survival following hepatic resection for metastatic colorectal cancer. World J Surg. 1998;22:399-404; discussion 404-5.
6. Di Martino E, Wild CP, Rotimi O, Darnton JS, Olliver RJ, Hardie LJ. IGFBP-3 and IGFBP-10 (CYR61) up-regulation during the development of Barrett's oesophagus and associated oesophageal adenocarcinoma: potential biomarkers of disease risk. Biomark-ers. 2006;11:547-61. (Pubitemid 44614826)
7. Yamazoe Y, Maetani S, Onodera H, Nishikawa T, Tobe T. Histopathological prediction of liver metastasis after curative resection of colorectal cancer. Surg Oncol. 1992;1:237-44.
8. Bird NC, Mangnall D, Majeed AW. Biology of colorectal liver metastases: a review. J Surg Oncol. 2006;94:68-80. (Pubitemid 43967727)
9. Ohji Y, Yao T, Eguchi T, et al. Evaluation of risk of liver metastasis in colorectal adenocarcinoma based on the combination of risk factors including CD10 expression: multivariate analysis of clinicopathological and immunohistochemical factors. Oncol Rep. 2007;17:525-30.
10. Barozzi C, Ravaioli M, D'Errico A, et al. Relevance of biologic markers in colorectal carcinoma: a comparative study of a broad panel. Cancer. 2002;94:647-57. (Pubitemid 34132292)
11. Takata O, Kawamura YJ, Konishi F, et al. cDNA array analysis for prediction of hepatic metastasis of colorectal carcinoma. Surg Today. 2006;36:608-14. (Pubitemid 43962100)
12. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin. 2011;61:69-90.
13. Li M, Lin YM, Hasegawa S, et al. Genes associated with liver metastasis of colon cancer, identified by genome-wide cDNA microarray. Int J Oncol. 2004;24:305-12.
14. Rhodes DR, Yu J, Shanker K, et al. ONCOMINE: a cancer microarray database and integrated data-mining platform. Neo-plasia. 2004;6:1-6. (Pubitemid 38391943)
15. Marquardt JU, Quasdorff M, Varnholt H, et al. Neighbor of punc E11, a novel oncofetal marker for hepatocellular carcinoma. Int J Cancer. 2010.
16. Monami G, Emiliozzi V, Bitto A, et al. Proepithelin regulates prostate cancer cell biology by promoting cell growth, migration, and anchorage-independent growth. Am J Pathol. 2009;174: 1037-47.
17. Smith DD, Saetrom P, Snove OJ, et al. Meta-analysis of breast cancer microarray studies in conjunction with conserved cis-elements suggest patterns for coordinate regulation. BMC Bio-informatics. 2008;9:63.
18. Yang Y, Pospisil P, Iyer LK, Adelstein SJ, Kassis AI. Integrative genomic data mining for discovery of potential blood-borne bio-markers for early diagnosis of cancer. PLoS One. 2008;3:e3661.
19. Tanami H, Tsuda H, Okabe S, et al. Involvement of cyclin D3 in liver metastasis of colorectal cancer, revealed by genome-wide copy-number analysis. Lab Invest. 2005;85:1118-29. (Pubitemid 43073985)
20. Wanebo HJ, Chu QD, Vezeridis MP, Soderberg C. Patient selection for hepatic resection of colorectal metastases. Arch Surg. 1996;131:322-9. (Pubitemid 26078821)
21. Ramaswamy S, Ross KN, Lander ES, Golub TR. A molecular signature of metastasis in primary solid tumors. Nat Genet. 2003;33:49-54. (Pubitemid 36068681)
22. Hu H, Sun L, Guo C, et al. Tumor cell-microenvironment interaction models coupled with clinical validation reveal CCL2 and SNCG as two predictors of colorectal cancer hepatic metastasis. Clin Cancer Res. 2009;15:5485-93.
23. Macri A, Versaci A, Lupo G, et al. Role of osteopontin in breast cancer patients. Tumori. 2009;95:48-52.
24. Sun Y, Wang L, Jiang M, Huang J, Liu A, Wolfl S. Secreted phosphoprotein 1 upstream invasive network construction and analysis of lung adenocarcinoma compared with human normal adjacent tissues by integrative biocomputation. Cell Biochem Biophys. 2010;56:59-71.
25. Yu HB, Han XB, Liang YQ, Liu JG, Wang H. Expression of osteopontin and survivin in prostate cancer and the clinical significance. Nan Fang Yi Ke Da Xue Xue Bao. 2010;30:1141-3.
26. Coppola D, Szabo M, Boulware D, et al. Correlation of osteo-pontin protein expression and pathological stage across a wide variety of tumor histologies. Clin Cancer Res. 2004;10(1 Pt. 1):184-90. (Pubitemid 38114178)
27. Lee JL, Wang MJ, Sudhir PR, Chen GD, Chi CW, Chen JY. Osteopontin promotes integrin activation through outside-in and inside-out mechanisms: OPN-CD44 V interaction enhances survival in gastrointestinal cancer cells. Cancer Res. 2007;67: 2089-97.
28. Allan AL, George R, Vantyghem SA, et al. Role of the integrin-binding protein osteopontin in lymphatic metastasis of breast cancer. Am J Pathol. 2006;169(1):233-46.
29. Ramankulov A, Lein M, Kristiansen G, Meyer HA, Loening SA, Jung K. Elevated plasma osteopontin as marker for distant metastases and poor survival in patients with renal cell carcinoma. J Cancer Res Clin Oncol. 2007;133(9):643-52. (Pubitemid 47077056)
30. Huntoon KM, Wang Y, Eppolito CA, et al. The acute phase protein haptoglobin regulates host immunity. J Leukoc Biol. 2008;84:170-81. (Pubitemid 351960292)
31. Abdullah M, Schultz H, Kahler D, et al. Expression of the acute phase protein haptoglobin in human lung cancer and tumor-free lung tissues. Pathol Res Pract. 2009;205:639-47.
32. Smeets MB, Fontijn J, Kavelaars A, Pasterkamp J, De Kleijn DPV. The acute phase protein haptoglobin is locally expressed in arthritic and oncological tissues. Int J Exp Pathol. 2003; 84:69-74. (Pubitemid 36754271)
33. Harvey S, Kohga S, Sait SN, et al. Co-expression of urokinase with haptoglobin in human carcinomas. J Surg Res. 2009;152: 189-97.
34. Lee CC, Ho HC, Lee MS, Hung SK, Yu CC, Su YC. Expression of haptoglobin predicts recurrence in head and neck squamous cell carcinoma. Clin Chim Acta. 2010;411:1116-21.